CHARLES SCHWAB INVESTMENT MANAGEMENT INC - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 81 filers reported holding RELMADA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$37,515
+22.0%
12,5050.0%0.00%
Q2 2023$30,762
-81.6%
12,505
-83.1%
0.00%
Q1 2023$167,048
-22.1%
73,915
+20.4%
0.00%
Q4 2022$214,321
-91.8%
61,410
-12.9%
0.00%
-100.0%
Q3 2022$2,611,000
+89.6%
70,515
-2.7%
0.00%
Q2 2022$1,377,000
-23.9%
72,506
+8.2%
0.00%
-100.0%
Q1 2022$1,809,000
+76.8%
66,996
+47.6%
0.00%
Q4 2021$1,023,000
-5.5%
45,375
+10.0%
0.00%
Q3 2021$1,082,000
-65.9%
41,257
-58.4%
0.00%
-100.0%
Q2 2021$3,175,000
-4.7%
99,167
+4.9%
0.00%0.0%
Q1 2021$3,330,000
+11.9%
94,562
+1.9%
0.00%0.0%
Q4 2020$2,977,000
-11.5%
92,828
+3.8%
0.00%
-50.0%
Q3 2020$3,365,000
-16.5%
89,436
-0.7%
0.00%0.0%
Q2 2020$4,031,000
+121.5%
90,056
+68.9%
0.00%
+100.0%
Q1 2020$1,820,000
-5.2%
53,328
+8.4%
0.00%0.0%
Q4 2019$1,919,00049,1870.00%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
VR Adviser, LLC 668,440$25,147,0004.92%
TANG CAPITAL MANAGEMENT LLC 500,000$18,810,0003.40%
ACUTA CAPITAL PARTNERS, LLC 277,000$10,421,0002.83%
PARSONS CAPITAL MANAGEMENT INC/RI 455,137$17,122,0001.67%
RTW INVESTMENTS, LP 1,511,337$56,857,0001.37%
Avoro Capital Advisors LLC 1,500,000$56,430,0000.80%
Pegasus Asset Management, Inc. 26,958$1,014,0000.64%
RA Capital Management 781,290$29,392,0000.54%
TIEDEMANN ADVISORS, LLC 269,839$10,151,0000.49%
Boxer Capital, LLC 300,000$11,286,0000.39%
View complete list of RELMADA THERAPEUTICS INC shareholders